Literature DB >> 29300050

NAFLD in 2017: Novel insights into mechanisms of disease progression.

Reenam S Khan1, Philip N Newsome1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29300050     DOI： 10.1038/nrgastro.2017.181

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.

Authors:  Kevin M Hart; Thomas Fabre; Joshua C Sciurba; Richard L Gieseck; Lee A Borthwick; Kevin M Vannella; Thomas H Acciani; Rafael de Queiroz Prado; Robert W Thompson; Sandra White; Genevieve Soucy; Marc Bilodeau; Thirumalai R Ramalingam; Joseph R Arron; Naglaa H Shoukry; Thomas A Wynn
Journal:  Sci Transl Med       Date:  2017-06-28       Impact factor: 17.956

Review 2.  Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.

Authors:  Avijit Majumdar; Steven A Curley; Xifeng Wu; Powel Brown; Jessica P Hwang; Kirti Shetty; Zhi-Xing Yao; Aiwu Ruth He; Shulin Li; Lior Katz; Patrizia Farci; Lopa Mishra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 46.802

3.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

4.  Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.

Authors:  Anthony B El-Khoueiry; Bruno Sangro; Thomas Yau; Todd S Crocenzi; Masatoshi Kudo; Chiun Hsu; Tae-You Kim; Su-Pin Choo; Jörg Trojan; Theodore H Welling; Tim Meyer; Yoon-Koo Kang; Winnie Yeo; Akhil Chopra; Jeffrey Anderson; Christine Dela Cruz; Lixin Lang; Jaclyn Neely; Hao Tang; Homa B Dastani; Ignacio Melero
Journal:  Lancet       Date:  2017-04-20       Impact factor: 79.321

Review 5.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

6.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

7.  Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.

Authors:  Shabnam Shalapour; Xue-Jia Lin; Ingmar N Bastian; John Brain; Alastair D Burt; Alexander A Aksenov; Alison F Vrbanac; Weihua Li; Andres Perkins; Takaji Matsutani; Zhenyu Zhong; Debanjan Dhar; Jose A Navas-Molina; Jun Xu; Rohit Loomba; Michael Downes; Ruth T Yu; Ronald M Evans; Pieter C Dorrestein; Rob Knight; Christopher Benner; Quentin M Anstee; Michael Karin
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

Review 8.  Cell death and cell death responses in liver disease: mechanisms and clinical relevance.

Authors:  Tom Luedde; Neil Kaplowitz; Robert F Schwabe
Journal:  Gastroenterology       Date:  2014-07-18       Impact factor: 22.682

9.  Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults.

Authors:  Jie Jiang; Mingzhu Lin; Yanfang Xu; Jin Shao; Xuejun Li; Huijie Zhang; Shuyu Yang
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

10.  Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.

Authors:  Liang Guo; Peng Zhang; Zhimin Chen; Houjun Xia; Siming Li; Yanqiao Zhang; Sune Kobberup; Weiping Zou; Jiandie D Lin
Journal:  J Clin Invest       Date:  2017-11-06       Impact factor: 14.808
  10 in total
  7 in total

Review 1.  Role of Innate lymphoid Cells in Obesity and Insulin Resistance.

Authors:  Hong Chen; Lijun Sun; Lu Feng; Yue Yin; Weizhen Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-27       Impact factor: 6.055

2.  Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease.

Authors:  Natalie Stiglund; Kristina Strand; Martin Cornillet; Per Stål; Anders Thorell; Christine L Zimmer; Erik Näslund; Silja Karlgren; Henrik Nilsson; Gunnar Mellgren; Johan Fernø; Hannes Hagström; Niklas K Björkström
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

3.  A Low Iron Diet Protects from Steatohepatitis in a Mouse Model.

Authors:  Lipika Salaye; Ielizaveta Bychkova; Sandy Sink; Alexander J Kovalic; Manish S Bharadwaj; Felipe Lorenzo; Shalini Jain; Alexandria V Harrison; Ashley T Davis; Katherine Turnbull; Nuwan T Meegalla; Soh-Hyun Lee; Robert Cooksey; George L Donati; Kylie Kavanagh; Herbert L Bonkovsky; Donald A McClain
Journal:  Nutrients       Date:  2019-09-10       Impact factor: 5.717

4.  Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles.

Authors:  Maoxing Pan; Yuanjun Deng; Chuiyang Zheng; Huan Nie; Kairui Tang; Yupei Zhang; Qinhe Yang
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-14       Impact factor: 2.629

5.  Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy.

Authors:  Shuyi Wang; Jun Tao; Huaguo Chen; Machender R Kandadi; Mingming Sun; Haixia Xu; Gary D Lopaschuk; Yan Lu; Junmeng Zheng; Hu Peng; Jun Ren
Journal:  Acta Pharm Sin B       Date:  2021-07-14       Impact factor: 11.413

Review 6.  Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease.

Authors:  Jin Wang; Wanping He; Ping-Ju Tsai; Pei-Hsuan Chen; Manxiang Ye; Jiao Guo; Zhengquan Su
Journal:  Lipids Health Dis       Date:  2020-04-13       Impact factor: 3.876

Review 7.  Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease.

Authors:  Muhammad Amir; Michael Yu; Peijian He; Shanthi Srinivasan
Journal:  Front Med (Lausanne)       Date:  2020-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.